This site is intended for health professionals only

Published on 2 July 2007

Share this story:

RELATED ARTICLES
Join us for new Clinical Excellence in Respiratory Care event
Dismayed reactions from sector over proposed GPhC fees increase
Dapagliflozin use in heart failure extended by NICE to reduce hospitalisations
Study confirms spironolactone safe and effective for treating acne in women
Calls for HCPs to respond to major conditions strategy consultation

EU new-drug cooperation urged

teaser

Access to innovative medicines for all European patients can only be possible if clear framework conditions for pricing and reimbursement are set at European Union level, according to Mr Rolf Schwanitz, State Secretary at Germany



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Biosimilars: the long and winding road to clinical equivalence
Common Covid-19 antiviral molnupiravir may cause mutation and transmission
Organisations join forces to create global alliance against antibiotic resistance
New data shows high therapeutic benefits of Boehringer Ingelheim drug
Actavis opens new headquarters in Switzerland
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x